Ionis Continues to Expand Its Cardiology and Neurology Portfolio, Supporting Narrow Moat
Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...
FiercePharma1d
Genentech, Novartis join forces to raise awareness of food allergies’ impact on families
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
Food Allergy Research & Education2d
FARE Teams Up with Genentech and Novartis to Launch Food Allergy Educational Initiative
To learn more about food allergies or access FARE resources, please visit foodallergy.org.
Hosted on MSN4d
2025 USA TODAY Ad Meter Marketing Spotlight: TCU's top 5 and bottom 5
Texas Christian University unveils its top 5 and bottom 5 for the 2025 USA TODAY Ad Meter Marketing Spotlight. See which ...